Related Experiment Video

Updated: May 31, 2026

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation
08:48

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation

Published on: June 30, 2015

β-arrestin1 mediates metastatic growth of breast cancer cells by facilitating HIF-1-dependent VEGF expression

S K Shenoy1, S Han, Y L Zhao

  • 1Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA. sudha@receptor-biol.duke.edu

Oncogene
|June 21, 2011
PubMed

Insights

Beta-arrestin1 regulates breast cancer cell survival during hypoxia by interacting with HIF-1α to increase VEGF-A. Targeting beta-arrestin1 nuclear export may offer new anti-angiogenic breast cancer therapies.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Signaling

Background:

  • Beta-arrestins (1 and 2) are adaptor proteins involved in G protein-coupled receptor desensitization.
  • Emerging roles include regulation of cancer cell migration and proliferation.
  • Beta-arrestin1's function in breast cancer under hypoxic conditions is largely unexplored.

Purpose of the Study:

  • To investigate the role of beta-arrestin1 in breast tumor colonization and cancer cell survival during hypoxia.
  • To elucidate the interaction between beta-arrestin1 and hypoxia-induced factor-1α (HIF-1α).
  • To explore the therapeutic potential of targeting beta-arrestin1 nuclear translocation.

Main Methods:

  • Studied beta-arrestin1 expression in breast tumor xenografts in nude mice.
  • Analyzed cancer cell viability under hypoxic conditions.
  • Investigated protein-protein interactions using co-immunoprecipitation and subcellular localization studies.
  • Examined the effects of thalidomide and imatinib mesylate on beta-arrestin1 and HIF-1α localization.

Main Results:

  • Beta-arrestin1 expression correlates with breast tumor colonization and cancer cell survival during hypoxia.
  • Beta-arrestin1 interacts with nuclear HIF-1α, enhancing HIF-1-dependent vascular endothelial growth factor-A (VEGF-A) transcription.
  • Increased beta-arrestin1 expression in human breast cancer tissues correlates with elevated VEGF-A levels.
  • Thalidomide and imatinib mesylate induce nuclear export of beta-arrestin1, affecting HIF-1α localization and VEGF signaling.

Conclusions:

  • Beta-arrestin1 plays a critical role in promoting breast cancer cell survival under hypoxia via VEGF signaling.
  • Targeting the nuclear translocation of beta-arrestin1 presents a potential therapeutic strategy for anti-angiogenic and breast cancer treatments.

More Related Videos

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Quantification of Breast Cancer Cell Invasiveness Using a Three-dimensional (3D) Model08:08

Quantification of Breast Cancer Cell Invasiveness Using a Three-dimensional (3D) Model

Published on: June 11, 2014

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...